PATH | VRL
Menu

Uptake of the Human Papillomavirus Vaccine in Kenya: Testing the Health Belief Model Through Pathway Modeling on Cohort Data

This article, published in Globalization and Health, reports the results of a study that investigated the utility of the Health Belief Model (HBM) in predicting uptake of human papillomavirus (HPV) vaccine in Kenya. The data demonstrated that perceiving oneself as well informed was the strongest predictor of vaccine uptake. Other HBM constructs only influenced willingness to vaccinate, which was not correlated with vaccination. The authors found little support for the HBM in the context of HPV vaccination in Kenya but recommend further study on additional variables that could increase the predictive value of the model.

Author: Vermandere H, van Stam M-A, Naanyu V, Michielsen K, Degomme O, Oort F

Published: 2016

» Visit web page (English)

(Located at globalizationandhealth.biomedcentral.com)

Citation: Vermandere H, van Stam M-A, Naanyu V, Michielsen K, Degomme O, Oort F. Uptake of the Human Papillomavirus Vaccine in Kenya: Testing the Health Belief Model Through Pathway Modeling on Cohort Data. Globalization and Health. 2016;12(72).

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV)

Topics: Introduction and service delivery, Disease/vaccine specific information

Regions: Africa